CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4/A Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Director acquired 38,538 shares (grant or award)
- 4 Grant or award Director acquired 35,225 shares (grant or award)
- 4 Grant or award Director acquired 35,115 shares (grant or award)
- 4 Grant or award Director acquired 66,254 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Other events
- 424B5 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K/A Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
Page 17 of 78 · 1,549 filings